These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8977234)

  • 1. Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease.
    Nichols WC; Antin JH; Lunetta KL; Terry VH; Hertel CE; Wheatley MA; Arnold ND; Siemieniak DR; Boehnke M; Ginsburg D
    Blood; 1996 Dec; 88(12):4429-34. PubMed ID: 8977234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD31 mismatching affects marrow transplantation outcome.
    Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
    Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis.
    Kögler G; Middleton PG; Wilke M; Rocha V; Esendam B; Enczmann J; Wernet P; Gluckman E; Querol S; Lecchi L; Goulmy E; Dickinson AM
    Transplantation; 2002 Oct; 74(8):1167-75. PubMed ID: 12438965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease.
    Behar E; Chao NJ; Hiraki DD; Krishnaswamy S; Brown BW; Zehnder JL; Grumet FC
    N Engl J Med; 1996 Feb; 334(5):286-91. PubMed ID: 8532023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation.
    Cavanagh G; Chapman CE; Carter V; Dickinson AM; Middleton PG
    Transplantation; 2005 Mar; 79(5):602-5. PubMed ID: 15753851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Cavet J; Dickinson AM; Norden J; Taylor PR; Jackson GH; Middleton PG
    Blood; 2001 Sep; 98(5):1594-600. PubMed ID: 11520812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants.
    Maruya E; Saji H; Seki S; Fujii Y; Kato K; Kai S; Hiraoka A; Kawa K; Hoshi Y; Ito K; Yokoyama S; Juji T
    Blood; 1998 Sep; 92(6):2169-76. PubMed ID: 9731077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation.
    Goodman RS; Ewing J; Evans PC; Craig J; Poulton K; Dyer PA; Marcus RE; Taylor CJ
    Bone Marrow Transplant; 2005 Jul; 36(2):151-6. PubMed ID: 15908974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants.
    Middleton PG; Taylor PR; Jackson G; Proctor SJ; Dickinson AM
    Blood; 1998 Nov; 92(10):3943-8. PubMed ID: 9808588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
    El-Chennawi FA; Kamel HA; Mosaad YM; El-Sherbini SM; El-Billey NA
    Hematology; 2006 Aug; 11(4):227-34. PubMed ID: 17178660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants.
    Cavet J; Middleton PG; Segall M; Noreen H; Davies SM; Dickinson AM
    Blood; 1999 Dec; 94(11):3941-6. PubMed ID: 10572111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
    Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
    Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor.
    Balduini CL; Frassoni F; Noris P; Klersy C; Iannone AM; Bacigalupo A; Giorgiani G; Di Pumpo M; Locatelli F
    Br J Haematol; 2001 Sep; 114(4):951-3. PubMed ID: 11564091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
    Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
    Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese.
    Morishima Y; Kodera Y; Hirabayashi N; Tanimoto M; Matsuyama T; Horibe K; Ohta H; Mizuno S; Morishita Y; Yamauchi T
    Bone Marrow Transplant; 1995 Feb; 15(2):235-9. PubMed ID: 7773212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of recipient-specific alloreactivity: is GVHD predictable?
    Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
    Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors.
    Gaziev D; Polchi P; Galimberti M; Angelucci E; Giardini C; Baronciani D; Erer B; Lucarelli G
    Transplantation; 1997 Mar; 63(6):854-60. PubMed ID: 9089226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.